Remark RO-TTE3-D Axleback Exhaust for 2017-20 Lexus IS/15+ RC (All Engines)

Vehicle Fitment

• 2017-2020 Lexus IS200t/IS250/IS300/IS350 (RWD & AWD)
• 2015-2022 Lexus RC200t/RC300/RC350 (RWD & AWD; excludes RC F)

Features

• Direct-bolt-on axle-back exhaust upgrade
• High-flow performance design for improved exhaust tone
• Burnt double-wall stainless steel tips for premium appearance
• T304 stainless steel mandrel-bent 2.5" piping
• Quad 3.5" slant-cut tip outlets
• OEM-style hanger and flange compatibility
• Reuses factory donut gaskets and spring hardware
• Enhances exhaust note without requiring cutting or welding

Specifications

• Part Number: RO-TTE3-D
• Exhaust Type: Axle-back, 2-piece bolt-on
• Piping Material: 16-gauge T304 stainless steel
• Piping Diameter: 2.5"
• Tip Material: T304 stainless steel
• Tip Diameter: 3.5" quad slant style
• Fitment: Left & right sides included
• Installation: Uses factory midpipe connection points

Included Components

• 1x Left axle-back exhaust section
• 1x Right axle-back exhaust section
• 1x Set of mounting flanges
• 1x Set of hardware for installation

Product Description

The Remark RO-TTE3-D Axleback Exhaust is a premium performance upgrade designed for select Lexus IS and RC models. Built from durable T304 stainless steel, this bolt-on axle-back exhaust replaces the restrictive factory mufflers and provides a more aggressive exhaust note with refined tone quality. The burnt double-wall tips offer a standout aesthetic and help complement the rear styling of your Lexus.

Installation is straightforward and requires no cutting or welding - the system reuses factory donut gaskets and spring bolts for a clean, secure fit. The mandrel-bent 2.5" piping enhances flow while maintaining OEM-like reliability. Ideal for enthusiasts seeking enhanced sound and exhaust presence without impacting emissions or triggering check-engine lights. Fitment is confirmed on 2017-2020 IS series and 2015-2022 RC series models (all trims and engine options), excluding the RC F. Fitment confirmed through 2022; 2023+ unconfirmed at time of listing.